-
1
-
-
0034655131
-
WWOX, a novel WW domaincontaining protein mapping to human chromosome 16q23.3- 24.1, a region frequently affected in breast cancer
-
A.K. Bednarek, K.J. Laflin, R.L. Daniel, Q. Liao, K.A. Hawkins and C.M. Aldaz, WWOX, a novel WW domaincontaining protein mapping to human chromosome 16q23.3- 24.1, a region frequently affected in breast cancer, Cancer Res 60 (2000), 2140-2145.
-
(2000)
Cancer Res
, vol.60
, pp. 2140-2145
-
-
Bednarek, A.K.1
Laflin, K.J.2
Daniel, R.L.3
Liao, Q.4
Hawkins, K.A.5
Aldaz, C.M.6
-
2
-
-
17444440946
-
Common chromosomal fragile site FRA16D sequence: Identification of the for gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells
-
K. Ried, M. Finnis, L. Hobson, M. Mangelsdorf, S. Dayan, J.K. Nancarrow, E.Woollatt, G. Kremmidiotis, A. Gardner and D. Venter, et al., Common chromosomal fragile site FRA16D sequence: Identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells, Hum Mol Genet 9 (2000), 1651-1663.
-
(2000)
Hum Mol Genet
, vol.9
, pp. 1651-1663
-
-
Ried, K.1
Finnis, M.2
Hobson, L.3
Mangelsdorf, M.4
Dayan, S.5
Nancarrow, J.K.6
Woollatt, E.7
Kremmidiotis, G.8
Gardner, A.9
Venter, D.10
-
3
-
-
0035949591
-
WWOX: A candidate tumor suppressor gene involved in multiple tumor types
-
A.J. Paige, K.J. Taylor, C. Taylor, S.G. Hillier, S. Farrington, D. Scott, D.J. Porteous, J.F. Smyth, H. Gabra and J.E. Watson, WWOX: A candidate tumor suppressor gene involved in multiple tumor types, Proc Natl Acad Sci U S A 98 (2001), 11417-11422.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 11417-11422
-
-
Paige, A.J.1
Taylor, K.J.2
Taylor, C.3
Hillier, S.G.4
Farrington, S.5
Scott, D.6
Porteous, D.J.7
Smyth, J.F.8
Gabra, H.9
Watson, J.E.10
-
4
-
-
85047700355
-
Alternative transcripts of the candidate tumor suppressor gene,WWOX, are expressed at high levels in human breast tumors
-
K. Driouch, H. Prydz, R. Monese, H. Johansen, R. Lidereau and E. Frengen, Alternative transcripts of the candidate tumor suppressor gene,WWOX, are expressed at high levels in human breast tumors, Oncogene 21 (2002), 1832-1840.
-
(2002)
Oncogene
, vol.21
, pp. 1832-1840
-
-
Driouch, K.1
Prydz, H.2
Monese, R.3
Johansen, H.4
Lidereau, R.5
Frengen, E.6
-
5
-
-
23044492008
-
WW domaincontaining proteins,WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function
-
R.I. Aqeilan, V. Donati, A. Palamarchuk, F. Trapasso, M. Kaou, Y. Pekarsky, M. Sudol and C.M. Croce, WW domaincontaining proteins,WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function, Cancer Res 65 (2005), 6764-6772.
-
(2005)
Cancer Res
, vol.65
, pp. 6764-6772
-
-
Aqeilan, R.I.1
Donati, V.2
Palamarchuk, A.3
Trapasso, F.4
Kaou, M.5
Pekarsky, Y.6
Sudol, M.7
Croce, C.M.8
-
6
-
-
2442479760
-
Alterations of common chromosome fragile sites in hematopoietic malignancies
-
H. Ishii and Y. Furukawa, Alterations of common chromosome fragile sites in hematopoietic malignancies, Int J Hematol 79 (2004), 238-242.
-
(2004)
Int J Hematol
, vol.79
, pp. 238-242
-
-
Ishii, H.1
Furukawa, Y.2
-
7
-
-
4344715921
-
Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma
-
S.W. Park, J. Ludes-Meyers, D.B. Zimonjic, M.E. Durkin, N.C. Popescu and C.M. Aldaz, Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma, Br J Cancer 91 (2004), 753-759.
-
(2004)
Br J Cancer
, vol.91
, pp. 753-759
-
-
Park, S.W.1
Ludes-Meyers, J.2
Zimonjic, D.B.3
Durkin, M.E.4
Popescu, N.C.5
Aldaz, C.M.6
-
8
-
-
22344436709
-
WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear
-
C. Gourley, A.J. Paige, K.J. Taylor, D. Scott, N.J. Francis, R. Rush, C.M. Aldaz, J.F. Smyth and H. Gabra, WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear, Int J Oncol 26 (2005), 1681-1689.
-
(2005)
Int J Oncol
, vol.26
, pp. 1681-1689
-
-
Gourley, C.1
Paige, A.J.2
Taylor, K.J.3
Scott, D.4
Francis, N.J.5
Rush, R.6
Aldaz, C.M.7
Smyth, J.F.8
Gabra, H.9
-
9
-
-
13244271314
-
17beta-Estradiol upregulates and activates WOX1/WWOXv1 andWOX2/WWOXv2 in vitro: Potential role in cancerous progression of breast and prostate to a premetastatic state in vivo
-
N.S. Chang, L. Schultz, L.J. Hsu, J. Lewis, M. Su and C.I. Sze, 17beta-Estradiol upregulates and activates WOX1/WWOXv1 andWOX2/WWOXv2 in vitro: Potential role in cancerous progression of breast and prostate to a premetastatic state in vivo, Oncogene 24 (2005), 714-723.
-
(2005)
Oncogene
, vol.24
, pp. 714-723
-
-
Chang, N.S.1
Schultz, L.2
Hsu, L.J.3
Lewis, J.4
Su, M.5
Sze, C.I.6
-
10
-
-
23844466267
-
WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo
-
F.J. Lai, C.L. Cheng, S.T. Chen, C.H. Wu, L.J. Hsu, J.Y. Lee, S.C. Chao, M.C. Sheen, C.L. Shen and N.S. Chang, et al., WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo, Clin Cancer Res 11 (2005), 5769-5777.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 5769-5777
-
-
Lai, F.J.1
Cheng, C.L.2
Chen, S.T.3
Wu, C.H.4
Hsu, L.J.5
Lee, J.Y.6
Chao, S.C.7
Sheen, M.C.8
Shen, C.L.9
Chang, N.S.10
-
11
-
-
0035793612
-
Hyaluronidase induction of a WW domaincontaining oxidoreductase that enhances tumor necrosis factor cytotoxicity
-
N.S. Chang, N. Pratt, J. Heath, L. Schultz, D. Sleve, G.B. Carey and N. Zevotek, Hyaluronidase induction of a WW domaincontaining oxidoreductase that enhances tumor necrosis factor cytotoxicity, J Biol Chem 276 (2001), 3361-3370.
-
(2001)
J Biol Chem
, vol.276
, pp. 3361-3370
-
-
Chang, N.S.1
Pratt, N.2
Heath, J.3
Schultz, L.4
Sleve, D.5
Carey, G.B.6
Zevotek, N.7
-
12
-
-
0038322051
-
JNK1 physically interacts withWWdomain-containing oxidoreductase(WOX1) and inhibits WOX1-mediated apoptosis
-
N.S. Chang, J. Doherty and A. Ensign, JNK1 physically interacts withWWdomain-containing oxidoreductase(WOX1) and inhibits WOX1-mediated apoptosis, J Biol Chem 278 (2003), 9195-9202.
-
(2003)
J Biol Chem
, vol.278
, pp. 9195-9202
-
-
Chang, N.S.1
Doherty, J.2
Ensign, A.3
-
13
-
-
30044438229
-
WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53
-
N.S. Chang, J. Doherty, A. Ensign, L. Schultz, L.J. Hsu and Q. Hong, WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53, J Biol Chem 280 (2005), 43100-43108.
-
(2005)
J Biol Chem
, vol.280
, pp. 43100-43108
-
-
Chang, N.S.1
Doherty, J.2
Ensign, A.3
Schultz, L.4
Hsu, L.J.5
Hong, Q.6
-
14
-
-
1542351221
-
Expression of WW domain-containing oxidoreductase WOX1in the developing murine nervous system
-
S.T. Chen, J.I. Chuang, J.P. Wang, M.S. Tsai, H. Li and N.S. Chang, Expression of WW domain-containing oxidoreductase WOX1in the developing murine nervous system, Neuroscience 124 (2004), 831-839.
-
(2004)
Neuroscience
, vol.124
, pp. 831-839
-
-
Chen, S.T.1
Chuang, J.I.2
Wang, J.P.3
Tsai, M.S.4
Li, H.5
Chang, N.S.6
-
15
-
-
12344311908
-
Light-induced retinal damage involves tyrosine 33 phosphorylation, mitochondrial and nuclear translocation of WW domain-containing oxidoreductase in vivo
-
S.T. Chen, J.I. Chuang, C.L. Cheng, L.J. Hsu and N.S. Chang, Light-induced retinal damage involves tyrosine 33 phosphorylation, mitochondrial and nuclear translocation of WW domain-containing oxidoreductase in vivo, Neuroscience 130 (2005), 397-407.
-
(2005)
Neuroscience
, vol.130
, pp. 397-407
-
-
Chen, S.T.1
Chuang, J.I.2
Cheng, C.L.3
Hsu, L.J.4
Chang, N.S.5
-
16
-
-
3142710158
-
Down-regulation of WW domaincontaining oxidoreductase induces Tau phosphorylation in vitro, A potential role in Alzheimer's disease
-
C.I. Sze, M. Su, S. Pugazhenthi, P. Jambal, L.J. Hsu, J. Heath, L. Schultz and N.S. Chang, Down-regulation of WW domaincontaining oxidoreductase induces Tau phosphorylation in vitro, A potential role in Alzheimer's disease. J Biol Chem 279 (2004), 30498-30506.
-
(2004)
J Biol Chem
, vol.279
, pp. 30498-30506
-
-
Sze, C.I.1
Su, M.2
Pugazhenthi, S.3
Jambal, P.4
Hsu, L.J.5
Heath, J.6
Schultz, L.7
Chang, N.S.8
-
20
-
-
18044399847
-
The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling
-
R.J. Shaw, J.G. Paez, M. Curto, A. Yaktine, W.M. Pruitt, I. Saotome, J.P. O'Bryan, V. Gupta, N. Ratner and C.J. Der, et al., The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling, Dev Cell 1 (2001), 63-72.
-
(2001)
Dev Cell
, vol.1
, pp. 63-72
-
-
Shaw, R.J.1
Paez, J.G.2
Curto, M.3
Yaktine, A.4
Pruitt, W.M.5
Saotome, I.6
O'bryan, J.P.7
Gupta, V.8
Ratner, N.9
Der, C.J.10
-
21
-
-
0038344831
-
Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells
-
K. Kaempchen, K. Mielke, T. Utermark, S. Langmesser and C.O. Hanemann, Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells, Hum Mol Genet 12 (2003), 1211-1221.
-
(2003)
Hum Mol Genet
, vol.12
, pp. 1211-1221
-
-
Kaempchen, K.1
Mielke, K.2
Utermark, T.3
Langmesser, S.4
Hanemann, C.O.5
-
22
-
-
10744229026
-
Merlin neutralizes the inhibitory effect of Mdm2 on p53
-
H. Kim, N.J. Kwak, J.Y. Lee, B.H. Choi, Y. Lim, Y.J. Ko, Y.H. Kim, P.W. Huh, K.H. Lee and H.K. Rha, et al., Merlin neutralizes the inhibitory effect of Mdm2 on p53, J Biol Chem 279 (2004), 7812-7818.
-
(2004)
J Biol Chem
, vol.279
, pp. 7812-7818
-
-
Kim, H.1
Kwak, N.J.2
Lee, J.Y.3
Choi, B.H.4
Lim, Y.5
Ko, Y.J.6
Kim, Y.H.7
Huh, P.W.8
Lee, K.H.9
Rha, H.K.10
-
23
-
-
0034940496
-
NF2 status of meningiomas is associated with tumour localization and histology
-
J. Kros, K. de Greve, A. van Tilborg, W. Hop, H. Pieterman, C. Avezaat, R. Lekanne Dit Deprez and E. Zwarthoff, NF2 status of meningiomas is associated with tumour localization and histology, J Pathol 194 (2001), 367-372.
-
(2001)
J Pathol
, vol.194
, pp. 367-372
-
-
Kros, J.1
De Greve, K.2
Van Tilborg, A.3
Hop, W.4
Pieterman, H.5
Avezaat, C.6
Lekanne Dit Deprez, R.7
Zwarthoff, E.8
-
24
-
-
0036239486
-
Evaluation of relationship between chromosome 22 and p53 gene alterations and the subtype of meningiomas by the interphase-FISH technique
-
T. Yakut, A. Bekar, M. Doygun, H. Acar, U. Egeli and E. Ogul, Evaluation of relationship between chromosome 22 and p53 gene alterations and the subtype of meningiomas by the interphase-FISH technique, Teratog Carcinog Mutagen 22 (2002), 217-225.
-
(2002)
Teratog Carcinog Mutagen
, vol.22
, pp. 217-225
-
-
Yakut, T.1
Bekar, A.2
Doygun, M.3
Acar, H.4
Egeli, U.5
Ogul, E.6
-
25
-
-
3242881204
-
Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas
-
S.M. Ranuncolo, M. Varela, A. Morandi, J. Lastiri, S. Christiansen, E. Bal de Kier Joffe, M.G. Pallotta and L. Puricelli, Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas, J Neurooncol 68 (2004), 113-121.
-
(2004)
J Neurooncol
, vol.68
, pp. 113-121
-
-
Ranuncolo, S.M.1
Varela, M.2
Morandi, A.3
Lastiri, J.4
Christiansen, S.5
De Kier Joffe Bal, E.6
Pallotta, M.G.7
Puricelli, L.8
-
26
-
-
0036943601
-
P53 Protein expression in meningiomas - A clinicopathologic study of 55 patients
-
P.H. Aguiar, C. Agner, R. Simm, A.B. Freitas, A.M. Tsanaclis and P. Plese, p53 Protein expression in meningiomas - a clinicopathologic study of 55 patients, Neurosurg Rev 25 (2002), 252-257.
-
(2002)
Neurosurg Rev
, vol.25
, pp. 252-257
-
-
Aguiar, P.H.1
Agner, C.2
Simm, R.3
Freitas, A.B.4
Tsanaclis, A.M.5
Plese, P.6
-
27
-
-
84866156432
-
Overexpression of WW domain-containing oxidoreductase WOX1 preferentially induces apoptosis in human glioblastoma cells harboring mutant p53
-
M.F. Chiang, S.T. Yeh, H.F. Liao, N.S. Chang and Y.J. Chen, Overexpression of WW domain-containing oxidoreductase WOX1 preferentially induces apoptosis in human glioblastoma cells harboring mutant p53, Biomed Pharmacother 66 (2012), 433-438.
-
(2012)
Biomed Pharmacother
, vol.66
, pp. 433-438
-
-
Chiang, M.F.1
Yeh, S.T.2
Liao, H.F.3
Chang, N.S.4
Chen, Y.J.5
|